Ratnakar Securities Pvt. Ltd.

BHARAT PARENTERALS LTD.

NSE : NABSE : 541096ISIN CODE : INE365Y01019Industry : Pharmaceuticals & DrugsHouse : Private

BSE1664.35-32.45 (-1.91 %)

PREV CLOSE ( ) 1696.80

OPEN PRICE ( ) 1697.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5097

TODAY'S LOW / HIGH ( )1627.05 1738.95

52 WK LOW / HIGH ( ) 321.21824.7

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992

Management Info

- Chairman Bharat Desai - Managing Director

Registered Office

Address Survey No. 144 A,Jarod - Samlaya Road,Haripura, Savli,
Vadodara,
Gujarat-391520

Phone 02667 - 251670, 251680, 9909928332

Email info@bplindia.in / cs@bplindia.in

Website www.bplindia.in

Registrars Details

Adroit Corporate Services Pvt Ltd

18-20, 1st floor, Plot No 639,Makwana Road,,Marol, Andheri (East),Mumbai

Listing : BSE

NEWS

29Apr Allotment of Equity Shares
Preferential Issue of shares Inter-alia, considered and approved the fo..

22Mar Bharat Parenterals informs about detai
Pursuant to Regulation 39(3) of the SEBI Listing Obligations and Disclos..

13Mar Bharat Parenteralsâ€™ arm signs deal w
Bharat Parenteralsâ€™ subsidiary Innoxel Lifesciences has signed a deal..

02Mar Bharat Parenterals informs about analy
Pursuant to Regulation 30 of the Listing Regulations read with clause 15..

03Feb Bharat Parenterals informs about loss
Pursuant to Regulation 39(3) of the SEBI Listing Obligations and Disclos..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	50.7	243.4
Gross Profit	69	321.7
Operating Profit	91.8	402.1
Net Sales	588	2179.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE) 4899.45 (2.36%)	M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Torrent Pharma (BSE) 2732.60 (2.20%)	M.Cap ( in Cr)92483.60

Shareholding Pattern

	PROMOTERS	73.27%
	NON-INSTITUTION	26.73%
	FI/BANKS/INSURANCE	0.01%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

BHARAT PARENTERALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES